Q32 Bio (STU:DB0) Operating Margin %: 0.00% (As of Mar. 2026)


STU:DB0 Q32 Bio Inc STU:DB0
17 GF Score
Price €9.65
! 2 Warning Signs
View Full Analysis

What is Q32 Bio Operating Margin %?

Q32 Bio STU:DB0 -5.76% 17 Operating Margin % is 0.00% as of Mar. 2026. GuruFocus rates STU:DB0 with a GF Score™ of 17/100. The stock has 2 warning signs investors should review. Among 945 Biotechnology companies, Q32 Bio ranks better than 95.56% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Q32 Bio's Operating Income for the three months ended in Mar. 2026 was €-6.68 Mil. Q32 Bio's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Q32 Bio's Operating Margin % for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Q32 Bio's Operating Margin % or its related term are showing as below:

STU:DB0' s Operating Margin % Range Over the Past 10 Years
Min: -589.76   Med: 31.45   Max: 725.53
Current: 39.84


STU:DB0's Operating Margin % is ranked better than
95.56% of 945 companies
in the Biotechnology industry
Industry Median: -86.89 vs STU:DB0: 39.84

Q32 Bio's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Q32 Bio's Operating Income for the three months ended in Mar. 2026 was €-6.68 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was €18.09 Mil.


Q32 Bio  (STU:DB0) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Q32 Bio Operating Margin % Related Terms


Q32 Bio Operating Margin % Historical Data

* Premium members only.

The historical data trend for Q32 Bio's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q32 Bio Operating Margin % Chart

Q32 Bio Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
0.00 -589.71 725.53 0.00 31.45

Q32 Bio Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 85.38 0.00

STU:DB0 vs ABOS, TNYA, MDWD: Operating Margin % Comparison

For the Biotechnology subindustry, Q32 Bio's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q32 Bio Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q32 Bio's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Q32 Bio's Operating Margin % falls into.


STU:DB0
17GF Score
Q32 Bio Inc STU:DB0
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q32 Bio Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Q32 Bio's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=14.434 / 45.891
=31.45 %

Q32 Bio's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-6.68 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 0.00% mean?
Q32 Bio (STU:DB0) has a Operating Margin % of 0.00% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Q32 Bio and its competitors. According to the industry distribution chart, Q32 Bio ranks #42 out of 945 companies in the Biotechnology industry, placing it in the top 4.4%.
Is Q32 Bio's Operating Margin % too high?
Q32 Bio's current Operating Margin % is 0.00%. Based on the distribution chart, Q32 Bio ranks #42 out of 945 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Q32 Bio has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Q32 Bio's Operating Margin % compare to ABOS and TNYA?
According to the Biotechnology industry distribution chart, Q32 Bio ranks #42 out of 945 companies for Operating Margin %. This places Q32 Bio in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Q32 Bio and its competitors. Q32 Bio's current Operating Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q32 Bio stock overvalued right now?
Q32 Bio (STU:DB0) has a current Operating Margin % of 0.00%. The current Operating Margin % is 0.00%. Q32 Bio's overall GF Score™ is 17/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Q32 Bio (STU:DB0), the current Operating Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q32 Bio Business Description

Other Exchanges QTTB:USADB0:Germany
Address 830 Winter Street, Waltham, MA, USA, 02451
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
17GF Score

Get the complete analysis for STU:DB0

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.65
Price